CN110432482A - A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN110432482A CN110432482A CN201910606011.7A CN201910606011A CN110432482A CN 110432482 A CN110432482 A CN 110432482A CN 201910606011 A CN201910606011 A CN 201910606011A CN 110432482 A CN110432482 A CN 110432482A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- allergic dermatitis
- powder
- acid
- infant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 48
- 201000008937 atopic dermatitis Diseases 0.000 title claims abstract description 47
- 206010012434 Dermatitis allergic Diseases 0.000 title claims abstract description 45
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 34
- 230000035764 nutrition Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 18
- 238000009472 formulation Methods 0.000 title claims description 13
- 239000000843 powder Substances 0.000 claims abstract description 76
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 27
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000015097 nutrients Nutrition 0.000 claims abstract description 19
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 18
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000013305 food Nutrition 0.000 claims abstract description 16
- 230000035622 drinking Effects 0.000 claims abstract description 15
- 235000008216 herbs Nutrition 0.000 claims abstract description 15
- 230000010354 integration Effects 0.000 claims abstract description 15
- 235000018102 proteins Nutrition 0.000 claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 239000011701 zinc Substances 0.000 claims abstract description 15
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 15
- 235000016804 zinc Nutrition 0.000 claims abstract description 15
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 13
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 13
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 13
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 12
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 12
- 235000019197 fats Nutrition 0.000 claims abstract description 12
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940046009 vitamin E Drugs 0.000 claims abstract description 12
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 12
- 239000011709 vitamin E Substances 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- 229910052742 iron Inorganic materials 0.000 claims abstract description 11
- 229960003284 iron Drugs 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 10
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 10
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 10
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 10
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 10
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960000304 folic acid Drugs 0.000 claims abstract description 9
- 235000019152 folic acid Nutrition 0.000 claims abstract description 9
- 239000011724 folic acid Substances 0.000 claims abstract description 9
- 239000001755 magnesium gluconate Substances 0.000 claims abstract description 9
- 235000015778 magnesium gluconate Nutrition 0.000 claims abstract description 9
- 229960003035 magnesium gluconate Drugs 0.000 claims abstract description 9
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims abstract description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 9
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 9
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 9
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims abstract description 8
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 6
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 3
- 239000003094 microcapsule Substances 0.000 claims description 21
- 239000011669 selenium Substances 0.000 claims description 16
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 14
- 229910052711 selenium Inorganic materials 0.000 claims description 14
- 229940091258 selenium supplement Drugs 0.000 claims description 14
- 235000001014 amino acid Nutrition 0.000 claims description 12
- 229940024606 amino acid Drugs 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 12
- 235000019198 oils Nutrition 0.000 claims description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 235000010755 mineral Nutrition 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 240000000171 Crataegus monogyna Species 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 235000021323 fish oil Nutrition 0.000 claims description 9
- 108010038807 Oligopeptides Proteins 0.000 claims description 8
- 102000015636 Oligopeptides Human genes 0.000 claims description 8
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 8
- 235000021388 linseed oil Nutrition 0.000 claims description 8
- 239000000944 linseed oil Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 7
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 7
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims description 7
- 230000003301 hydrolyzing effect Effects 0.000 claims description 7
- 239000006041 probiotic Substances 0.000 claims description 7
- 235000018291 probiotics Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000005913 Maltodextrin Substances 0.000 claims description 6
- 229920002774 Maltodextrin Polymers 0.000 claims description 6
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 6
- 239000010495 camellia oil Substances 0.000 claims description 6
- 229940035034 maltodextrin Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 241000205585 Aquilegia canadensis Species 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- 241000234435 Lilium Species 0.000 claims description 5
- 235000004347 Perilla Nutrition 0.000 claims description 5
- 244000124853 Perilla frutescens Species 0.000 claims description 5
- 244000197580 Poria cocos Species 0.000 claims description 5
- 235000008599 Poria cocos Nutrition 0.000 claims description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 5
- 241000219784 Sophora Species 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 5
- 241000251468 Actinopterygii Species 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 4
- 235000013717 Houttuynia Nutrition 0.000 claims description 4
- 240000000691 Houttuynia cordata Species 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- 244000234609 Portulaca oleracea Species 0.000 claims description 4
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 244000098338 Triticum aestivum Species 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 235000021342 arachidonic acid Nutrition 0.000 claims description 4
- 229940114079 arachidonic acid Drugs 0.000 claims description 4
- -1 citrulling Chemical compound 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 3
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 3
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 3
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 3
- 244000111489 Gardenia augusta Species 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 102000007544 Whey Proteins Human genes 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000013601 eggs Nutrition 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 2
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- 229930182816 L-glutamine Natural products 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 240000004371 Panax ginseng Species 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 240000001949 Taraxacum officinale Species 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 210000003022 colostrum Anatomy 0.000 claims description 2
- 235000021277 colostrum Nutrition 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 2
- 229960002733 gamolenic acid Drugs 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 244000237330 gutta percha tree Species 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 239000008165 rice bran oil Substances 0.000 claims description 2
- 239000011781 sodium selenite Substances 0.000 claims description 2
- 235000015921 sodium selenite Nutrition 0.000 claims description 2
- 229960001471 sodium selenite Drugs 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 235000008521 threonine Nutrition 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 235000008939 whole milk Nutrition 0.000 claims description 2
- 235000010930 zeaxanthin Nutrition 0.000 claims description 2
- 239000001775 zeaxanthin Substances 0.000 claims description 2
- 229940043269 zeaxanthin Drugs 0.000 claims description 2
- 235000021241 α-lactalbumin Nutrition 0.000 claims description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 3
- 241000186660 Lactobacillus Species 0.000 claims 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 2
- 229940039696 lactobacillus Drugs 0.000 claims 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 235000006484 Paeonia officinalis Nutrition 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 1
- 239000004519 grease Substances 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 9
- 229960005069 calcium Drugs 0.000 abstract description 9
- 235000019155 vitamin A Nutrition 0.000 abstract description 9
- 239000011719 vitamin A Substances 0.000 abstract description 9
- 229940045997 vitamin a Drugs 0.000 abstract description 9
- 238000007086 side reaction Methods 0.000 abstract description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 230000001228 trophic effect Effects 0.000 abstract description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 2
- 230000000306 recurrent effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 32
- 210000004072 lung Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000006673 asthma Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 210000000987 immune system Anatomy 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- 235000013312 flour Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 235000004879 dioscorea Nutrition 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- 206010044565 Tremor Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 208000030961 allergic reaction Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 244000116699 Lactobacillus acidophilus NCFM Species 0.000 description 3
- 235000009195 Lactobacillus acidophilus NCFM Nutrition 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000010903 husk Substances 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 208000012657 Atopic disease Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229940047122 interleukins Drugs 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical class O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010053779 Allergic cough Diseases 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 241000254697 Lactobacillus rhamnosus HN001 Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000005079 Malus baccata Nutrition 0.000 description 1
- 244000134336 Malus baccata Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 241000231739 Rutilus rutilus Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 235000003484 annual ragweed Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 208000029771 childhood onset asthma Diseases 0.000 description 1
- 235000003488 common ragweed Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000032686 female pregnancy Effects 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000011640 ferrous citrate Substances 0.000 description 1
- 235000019850 ferrous citrate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000004833 fish glue Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- APVZWAOKZPNDNR-UHFFFAOYSA-L iron(ii) citrate Chemical compound [Fe+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O APVZWAOKZPNDNR-UHFFFAOYSA-L 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000031942 natural killer cell mediated cytotoxicity Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920002997 teichuronic acid Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of infant allergic dermatitis tailored version clinical nutrition formulas comprising: protein, fat, dietary fiber, new resource food, integration of drinking and medicinal herbs ingredient, magnesium gluconate, calcium, iron, zinc, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, pantothenic acid, niacin, folic acid, grape seed extract, Kelp Powder.The present invention is based on the nutrition intakes of infant allergic dermatitis patients; by selecting reasonable basal nutrient element; the specific nutrient that there is protection function of intestinal canal and nutrition auxiliary to support for addition simultaneously; to improve infant allergic dermatitis patients trophic structure; there is preferable therapeutic effect for allergic dermatitis and its recurrent is lower; side reaction is smaller, can assist in the treatment of infant allergic dermatitis.
Description
Technical field
The present invention relates to special medicine purposes formula food fields, and in particular to a kind of infant allergic dermatitis tailored version faces
Bed nutrient formulation and preparation method thereof.
Background technique
Allergy is the immune system of body to the unconformable reaction of foreign substance, in fact to a kind of body not wound at last
Evil.Immune system is a kind of highly complex defense mechanism, and group human body can be helped to anti-infective.Immune system can first recognize external
Invasion substance, can drive later intracorporal leukocyte cell go attack foreign substance.For certain people, immune system
Some innocuous substances can be misdeemed as invader, while leukocyte cell overreact, it can be than invasion to injury caused by body
Injury caused by object is more.Therefore, allergic reaction itself forms a kind of disease.
Typical allergic reaction will appear nasal congestion, cough, asthma, itch, is short of breath, having a headache, tired and nettle rash
And other fash.The substance that can be caused allergic reaction is known as anaphylactogen.Substantially any substance can cause certain in the world
The allergic reaction of certain people in place.
The disease incidence of infant allergic disease such as asthma, allergic rhinitis, eczema, allergic dermatitis etc. has year by year in recent years
The trend increased becomes one of the principal disease for endangering children's health.20 kinds of common children's anaphylactogens are peanut, roach
Dung beetle, crab, marine fish combination, fresh-water fishes combination, egg white, trees, selects mould, argy wormwood, cat, milk, shrimp, dog, room at acarid combination
Dirt, soybean, beef, mutton, common ragweed, hops.The infant that slight allergic dermatitis occurs is likely to occur contrafluxion, scabies
Itch, edge can find the light blood cake removed;Water scar, big can then occur on the basis of erythema for severe allergic dermatitis infant
Scar, papule, exudation, erosion etc., infant will appear after itch is hard to bear and feeling of pain, but above-mentioned symptom occur in children, due to expression
Unclear or parent does not pay attention to and infant is caused excessively to scratch allergy position, causes to infect.Allergic dermatitis disease occurs for children
It is related with infant itself constitution, it is also closely related with extraneous factor.
Currently used for treating the measure of infant allergic dermatitis mainly based on Chinese materia medica preparation, ointment, bath foam, such as in
State patent CN105521117A discloses a kind of prescription of water extraction object treatment allergic dermatitis using component pericarpium zanthoxyli;Chinese patent
CN108686040A discloses a kind of dermatitis ointment, which includes following raw material: realgar, the root of Dahurain angelica, litharge, Chinese gall, soil
Chaste tree skin, borneol, camellia oil, dried peppermint leaf, vaseline;Chinese patent CN107854396A provide it is a kind of prevent dermatitis body lotion,
It is prepared from the following raw materials in parts by weight: 5-8 parts of Flos Lonicerae extractive solution, 4-6 parts of PORIA ALBA extracting solution, the bletilla striata-red sage root extract 3-9
Part, 0.5-1.8 parts of stearine, 0.8-1.5 parts of Butyrospermum parkii fruit oil, 4-7.5 parts of olive oil, 0.1-0.4 parts of carbomer,
20-40 parts of water.But above-mentioned each patent does not consider to be adjusted improvement from the dietary structure of body, at present also without it is any about
The report of the enteral nutrition preparation product of infant allergic dermatitis.
Summary of the invention
The purpose of the present invention is to overcome the defects in the prior art, not for infant allergic dermatitis patients dietary structure
Rationally, the bad statuses such as nutrition is uneven, mainly by Diet Adjustment, reasonably combined carbohydrate, protein, fat
Energy ratio is supplied, multivitamin, minerals, integration of drinking and medicinal herbs and new resource food, Lai Gaishan class infant allergic skin are selected
Scorching patient's trophic structure, auxiliary improve the body health situation of infant allergic dermatitis patients.
To achieve the above object, the present invention adopts the following technical scheme:
The first purpose of the invention is to provide a kind of infant allergic dermatitis tailored version clinical nutrition formulas comprising such as
Lower component and its parts by weight: including following component and its parts by weight: 23~35 parts of protein, fatty 28~37 parts, diet
18~23 parts of fiber, 3~6 parts of new resource food, 2~15 parts of integration of drinking and medicinal herbs ingredient, 4~7 parts of magnesium gluconate, calcium 0.4~0.6
Part, 0.015~0.02 part of iron, 0.010~0.015 part of zinc, 0.001~0.0015 part of vitamin A, vitamin D30.0004~
0.0008 part, 0.01~0.03 part of vitamin E, vitamin B10.001~0.005 part, vitamin B20.001~0.004 part,
Vitamin B60.001~0.004 part, vitamin B120.000002~0.000008 part, 0.1~0.3 part of vitamin C, pantothenic acid
0.003~0.007 part, 0.01~0.02 part of niacin, 0.01~0.04 part of folic acid, 0.01~0.5 part of grape seed extract, kelp
0.5~2 part of powder.
In order to advanced optimize above-mentioned clinical nutrition formula, technical measures adopted by the present invention further include:
Further, the protein is selected from hydrolyzing lactoalbumin powder, concentrated whey protein powder, soybean protein isolate, complete
Powdered egg, bovine colostrum, whole milk powder, ovalbumin peptide, soybean peptide, ocean fish oligopeptide, wheat oligopeptide, corn oligopeptide powder,
At least one of alpha lactalbumin powder, Isin glue collagen Gly-His-Lys, amino acid.More preferably: hydrolyzing lactoalbumin powder and fish glue
Former protein peptide powder.The preferred high-quality protein of above-mentioned protein, the present invention is by supplementing appropriate high biological value good protein, comprehensively
8 kinds for balancedly supplementing needed by human body must amino acid.
Further, the amino acid be selected from L-Glutamine, glycine, lysine, serine, arginine, alanine,
Methionine, tryptophan, leucine, isoleucine, valine, histidine, tyrosine, phenylalanine, citrulling, ornithine, day
At least one of aspartic acid, threonine, glutamic acid, cystine.Amino acid is the basic unit of constitutive protein matter, according to human body
Aggregate velocity and synthesis capability, being divided into essential amino acid, nonessential amino acid and condition must amino acid.Glutamine synthesis
One of matrix of DNA is played an important role in synthetic proteins matter, is the amino that unique one kind can directly pass through cerebrovascular barrier
Acid has the function of strengthen immunity for the leading substance of the immunocyte quickly divided.Glycine has prevention and treatment tissue damage,
Oxidation resistance is improved, immunity of organisms is improved, promotes protein synthesis, treats diabetes, the ischemia-reperfusion of metabolic disorder
Damage, the effect of cancer and various inflammatory diseases.Lysine improve food protein absorption and utilization, reach it is balanced nutritious,
Promote growth, improve memory, body is helped to generate antibody, hormone and enzyme, improves immunity of organisms, increases hemochrome, prevention
The effects of cardiovascular and cerebrovascular disease, the growth for promoting bone and cartilaginous tissue, treatment osteoporosis.Serine is in fat and fatty acid
It plays a role in metabolism and the growth of muscle, and facilitates the generation of immunoglobulin and antibody, therefore serine exists
The important role of performer in terms of immune system.Arginine is mainly sent out by NO approach and adjusting organism endocrine hormone
Immunoregulation effect is waved, promotes immunoglobulin to generate, plays an important role in terms of immunity of organism, Intestinal mucosa function.
Alanine is mainly the synthesis for participating in histone, deamination generates pyruvic acid and glutamic acid, decarboxylation generate pyruvic acid.In disease
Reaction of the energy to immune system relative to disease is very important in sick development process, therefore body tissue is big from blood
Amount absorbs alanine to promote glycometabolism be that body energizes, and reinforces autoimmunity with this.Methionine facilitates various in human body
Sulfur-containing compound metabolism and the methyl contained by it methylated to Toxic or drug and play the role of removing toxic substances.Group ammonia
Acid reduces gastric acidity, mitigates the pain of gastrointestinal procedures, mitigates gestational period vomiting and scorching hot sense, inhibits tight by vegetative nerve
Alimentary canal caused by festers, also powerful to anaphylactia, such as asthma;Tryptophan can prevent pellagra, depression
Disease improves sleep and adjusts mood.Three kinds of common amino acids in protein, i.e. leucine, isoleucine and valine are united
Claim branched-chain amino acid.This amino acid promotes body anabolism by release insulin and growth hormone, and in addition there are anti-
The effect of fatigue.Leucine can repair muscle, control blood glucose, and provide energy to bodily tissue, it is necessary to amino acid phenylpropyl alcohol ammonia
Acid can inhibit cancer growth, and can reduce the toxic side effect of drug.
Further, the integration of drinking and medicinal herbs ingredient is selected from Radix Glycyrrhizae, Poria cocos, peach kernel, sophora flower, rhizoma imperatae, semen coicis, dent
At least one of amaranth, lily, honeysuckle, cordate houttuynia, cape jasmine, dandelion, purple perilla seed, hawthorn, Chinese yam;More preferably: Pu Gong
Ying Fen, hawthorn powder, yam flour;Further, the Chinese medicine of integration of drinking and medicinal herbs is by processing, being ground into 100-200 targeted fine powder.
Allergic dermatitis category traditional Chinese medicine " wet sore ", " dip dyeing sore " scope, mostly because of spleen insufficiency, damp evil hinders mechanism of qi or wind formation from blood deficiency raw
Dry, skin mistake causes QI-blood circulation not normal in moistening inflammation, damp and hot to accumulate caused by resistance.Above-mentioned integration of drinking and medicinal herbs ingredient is with nourishing the blood to expel wind, heat-clearing
Based on dampness removing, invigorating the spleen to dry, so as to improve the symptom of infant allergic dermatitis.Radix Glycyrrhizae: sweet and neutral, return heart, lung, spleen, stomach meridian, tool
It invigorates the spleen and benefits qi, it is clearing heat and detoxicating, the effect of expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.Poria cocos: it is sweet, light, flat, return heart, lung,
Spleen, kidney channel have the effect of clearing damp and promoting diuresis, invigorating the spleen, calming heart.Peach kernel: there is promoting blood circulation to dispel for bitter, sweet, flat, return heart, liver, large intestine channel
The stasis of blood, relax bowel and defecation, relieving cough and asthma effect.Sophora flower: it is bitter, slightly cold, return liver, large intestine channel, there is cooling blood and hemostasis, the function of clearing liver-fire
Effect.Rhizoma imperatae: sweet, cold, return lung, stomach, bladder meridian have the effect of cooling blood and hemostasis, reducing fever and causing diuresis.Semen coicis: it is sweet, light, cool, return
Spleen, stomach, lung channel have the effect of clearing damp and promoting diuresis, invigorating the spleen to arrest diarrhea, eliminating impediment, apocenosis, detoxicating and resolving a mass.Purslane: acid, tremble with fear, return liver,
Large intestine channel has the effect of clearing heat and detoxicating, cooling blood and hemostasis, stop dysentery.Lily: it is sweet, it trembles with fear, distributed in heart and lung channels have Yin nourishing and lung moistening, clearly
The effect of heart and tranquilizing mind.Honeysuckle: it is sweet, it trembles with fear, return lung, the heart, stomach meridian have the effect of clearing heat and detoxicating, dispelling wind and heat from the body.Cordate houttuynia: it is pungent,
It is slightly cold, it is distributed in lung channel, there is the effect of clearing heat and detoxicating, the carbuncle that disappears toxin expelling, inducing diuresis for treating strangurtia.Cape jasmine: it is bitter, it trembles with fear, return heart, lung, tri-jiao channel, tool
There is the effect of purging intense heat relieving restlessness, reducing fever and causing diuresis, removing pattogenic heat from the blood and toxic material from the body.Dandelion: it is bitter, it is sweet, it trembles with fear, returns liver, stomach meridian, have clearing heat and detoxicating, disappear
The effect of swollen dissipating bind, inducing diuresis for treating strangurtia.Purple perilla seed: it is acrid in flavour and warm in nature, it is distributed in lung channel, there is lowering the adverse-rising QI to resolve phlegm, relieving cough and asthma, the function of relax bowel and defecation
Effect.Peppermint: pungent, cool, return lung, Liver Channel have the effect of dispelling wind and heat from the body, head clearing, relieving sore-throat, promoting eruption, soothing the liver promoting the circulation of qi.Hawthorn:
Sour, sweet, tepor, returns spleen, stomach, Liver Channel, food digesting stomach fortifying, scattered stasis have coronary artery dilator, vasodilator, blood fat-reducing blood pressure-decreasing strong
The effect of the heart.Chinese yam: sweet and neutral, returns spleen, lung, kidney channel have the effect of tonifying spleen nourishing the stomach, engender liquid and benefic lung, kidney tonifying arresting seminal emission.
Further, the new resource food is selected from DHA algal oil, arachidonic acid oil, gamma-linolenic acid oil, tree peony
Seed oil, tea seed oil, samara oil, imperial rice bran oil, conjugated linoleic acid, eucommia ulmoides seed oil, Oligomeric manna sugar, wheat oligopeptide, chitosan,
At least one of ginseng (artificial growth), zeaxanthin, hydrolysis yolk powder, the luxuriant Cillium of circle.More preferably: circle bud vehicle
Preceding sub- shell powder.Oil substances therein are added in the form of microcapsule powder.Chitosan belongs to high polycation, and active group band is just
Bacterial adsorption can be sticked together by charge, prevent its diffusion, after adsorbing bacterium, destroy the cell membrane of bacterium, cause cytoplasm
Interior DNA and RNA outflow, to achieve the effect that kill bacterium.The acid that cation can also generate simultaneously with bacterium surface
The interaction such as matter such as lipopolysaccharides, techoic acid, teichuronic acid, capsular polysaccharide, forms complicated polyelectrolyte, from
And so that the cell membrane function of bacterium is got muddled, is dead.Circle bud isapgol husk is rich in hemicellulose, this fiber cannot be by human body
Digestion, can promote growth of probiotics into enteron aisle, to reduce the quantity of harmful bacteria;Circle bud isapgol husk can water swelling
50-100 times, the jellied viscous substance of shape promotes enteron aisle normally to empty;Circle bud isapgol husk contains dietary fiber abundant,
And mainly water-soluble dietary fiber not will increase caloric intake.
Further, the fat is selected from olive oil microcapsule powder, tea oil microcapsule powder, fish oil microcapsule powder, two dodecahexaenes
At least one of acid lipid, arachidonic acid oil, linseed oil microcapsule powder, more preferably: linseed oil microcapsule powder, fish oil
Microcapsule powder;Wherein saturated fatty acid: monounsaturated fatty acids: the weight ratio of polyunsaturated fatty acid is about 1:1:1.Olive oil
79%-83% is reached with (C18:1) content of oleic acid in tea oil.There is anti-inflammatory and immunosuppressive action rich in n-3 fatty acid diets.Fish oil
Intake, which increases, can reduce childhood asthma, persistent cough, stridulates and the rapid symptom of night respiration.One having in the progress of female pregnancy period
The randomized control study discovery of n-3 polyunsaturated fatty acid is closed, mother's pregnancy period, which supplements polyunsaturated fatty acid, can reduce antigen spy
The product of the specific cell factor, and skin skin prick test positive rate and serious allergic rhinitis when can reduce baby 1 years old
Generation.Another research discovery mother's pregnancy period, which increases n-3 fatty acid and limits the intake of n-6 fatty acid, makes 18 months childs'
Wheezing symptoms mitigate, and when can substantially reduce children 3 years old allergic cough generation.
Further, the dietary fiber be selected from inulin, polydextrose, galactooligosaccharide, oligofructose, xylo-oligosaccharide,
At least one of grain dietary fibers such as oligoisomaltose, resistant dextrin, soybean fiber;More preferably: oligofructose.Meals
Food fiber can influence gastrointestinal function and influence allergic dermatitis indirectly.
Further, the nutrient formulation further includes 1~5 part of probiotics, and the probiotics is selected from Bifidobacterium, newborn bar
Pseudomonas, streptococcus, lactobacillus acidophilus NCFM, animal bifidobacteria Bb-12, bifidobacterium lactis HN019, bifidobacterium lactis Bi-
07, Lactobacillus rhamnosus LGG, Lactobacillus rhamnosus HN001, lactobacillus fermenti CECT5716, in bifidobacterium breve M-16V extremely
Few one kind.Previous research thinks that the interaction between heredity, environmental factor decides the performance and development of anaphylactia.At present
Studies have shown that the generation of infant allergic disease forms that initialization procedure is related with immune, the variation of intestinal microflora is to mistake
The occurrence and development of quick property disease also play an important role.Because probiotics can be colonized in enteron aisle and form biological protection barrier, resist
The intrusion of pathogenic microorganisms and anaphylaxis antigenic substance, makes children from enteric infection and anaphylactia.Probiotics has been at present
It is widely used in clinical prevention and treats a variety of diseases, especially in child infectious diarrhea, antibiotic-associated diarrhea, inflammatory bowel
Significant curative effect is achieved in the treatments of diseases such as disease, functional consitipation, indigestion and newborn's yellow subcutaneous ulcer.
Further, the nutrient formulation further includes 0.003~0.05 part of selenium, and the selenium derives from sodium selenite, selenium-rich
At least one of powder of edible fungus, Se-enriched yeast.
Further, vitamin A derives from least one of retinol acetate, retinyl palmitate, beta carotene.
Further, vitamin C sources are at least one of L-AA, L-AA sodium.
Further, source of vitamin E is in d- alpha-tocopherol, dl- alpha-tocopherol, d- α-D-α-tocopherol acetate, dl- α-acetic acid
At least one of tocopherol, d- α-tocopheryl succinate, dl- α-tocopheryl succinate.Vitamin E can promote n-3 fatty acid
Effect prolong some researches show that interleukins (IL) -6, IL-10, IL-12 and tumor necrosis factor (TNF)-alpha levels are adjusted
The generation of slow rat model autoimmune disease.
Further, vitamin D derives from least one of Vitamin D3, ergocalciferol.
Further, vitamin B1From at least one of thiamine hydrochloride, Thiamin mononitrate.
Further, vitamin B2From at least one of riboflavin.
Further, vitamin B6From at least one of puridoxine hydrochloride, pyridoxime 5'-phosphate.
Further, vitamin B12From at least one of cyanocobalamin, hydrochloric acid cyanocobalamin.
Further, zinc is from zinc sulfate, zinc gluconate, zinc oxide, zinc lactate, at least one in zinc citrate
Kind.
Further, iron is sub- from ferrous gluconate, ferrous citrate, ironic citrate, ferrous fumarate, lactic acid
At least one of iron, ferric pyrophosphate.
Further, calcium source in calcium carbonate, calcium gluconate, calcium citrate, calcium lactate, L-calcium lactate, calcium monohydrogen phosphate,
At least one of calcium phosphate.
Further, the infant allergic dermatitis tailored version clinical nutrition formula includes linseed oil microcapsule powder, hydrolysis
PURE WHEY, oligofructose, Isin glue collagen Gly-His-Lys, fish oil microcapsule powder, magnesium gluconate, circle luxuriant Cillium, Pu Gong
Ying Fen, hawthorn powder, yam flour, Kelp Powder, calcium, iron, zinc, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2、
Vitamin B6, vitamin B12, vitamin C, pantothenic acid, niacin, folic acid, grape seed extract.The nutrient formulation further include: smart ammonia
Acid, glutamine, Radix Glycyrrhizae, Poria cocos, peach kernel, sophora flower, rhizoma imperatae, semen coicis, purslane, lily, honeysuckle, cordate houttuynia, cape jasmine,
Purple perilla seed, chitosan, lactobacillus acidophilus NCFM, bifidobacterium lactis HN019, selenium.
In above-mentioned nutrient formulation, minerals are important nutrients necessary to human body, and many minerals are immune systems
Important composition ingredient, and certain minerals also have different degrees of influence to atopic diseases such as asthma.
Selenium is the confactor of antioxidant catalyzing enzyme.It can be reduced hydroperoxides and other organic peroxides.Cause
This plays critical effect in protecting cells from oxidative damage.In adult's research, asthmatic patient serum and diet are taken the photograph
The selenium level entered is lower than control group.Also some researches show that asthmatic patient Serum selenium levels and activity of glutathione peroxidase
It is lower.In addition, the discovery selenium intake such as Shaheen can reduce Adults Asthma;And it (is especially smoking in most researchs in relation to selenium
Crowd) in, it can also obtain High level of selenium conclusion relevant to preferable lung function.
Magnesium passes through relaxation bronchial smooth muscle and plays an important role in terms for the treatment of and preventing asthma.In child study
The effect that children apply bronchodilators can be improved in middle discovery, magnesium supplement.
Zinc is necessary to many components of immune system, including phagocyte and Natural killer activity, cellular immunity
And humoral immunity.Zinc has convergence antibacterial, and the mucous membrane surface of a wound can be made to form film, has protective effect.There are also studies have shown thats persistently to mend
Immune response can be repaired by filling zinc about 1-2 months of physiological dose, and can reduce the generation of infection event.Soutar etc. is mentioned
The too low risk that can make one to suffer from atopic diseases, the reaction of bronchus height and allergy symptoms of zinc intake increases in diet out.
In addition, lung tissue by different Antioxidation Mechanisms protect itself from damage, and zinc can then be played the part of by certain mechanism it is anti-
The role of oxidant.
Vitamin D is unified selective modulator of siberian crabapple, it can be because of exposure duration not to the effect of immunocyte
It is same and different.1,25(OH)2D3It is the active metabolite of internal vitamin D, research confirms 1,25 (OH) both at home and abroad2D3
In addition to adjusting internal alcium and phosphor metabolization, also there is extensive effect to immune system.
Vitamin E can increase the resistance to infection.To normal immunocompetence is maintained, especially to T lymphocyte
Function is critically important.
In breast-fed babies, the vitamin C of higher concentration and atopic dermatitis at its baby 12 months in breast milk
It is related with antigen anaphylactia onset risk reduction.
Grape seed extract is a kind of polyphenols extracted from grape seeds, and polyphenol content is wrapped 95% or more
Containing free phenol and polymerized polyphenolic, free phenol is mainly that catechin, epicatechin, gallic acid and catechin, epicatechin do not have
Infanticide acid esters, polymerized polyphenolic are keyed the procyanidine of the different polymerization degree formed by free phenol by C4~C6 or C4~C8,
The degree of polymerization is lower, and inoxidizability is stronger.Grape seed extract has anti-oxidant, free radical capture, metal ion-chelant, protein
In conjunction with etc. bioactivity, wherein bioactivity most outstanding is inoxidizability.Grape seed extract antioxidation mechanism is at least
There are three types of: a. carries out dehydrogenation reaction by phenolic hydroxyl group and free radical and generates stable Semiquinone Radicals, to interrupt chain reaction;
B. electronics is directly given by the effect of grape seed extract reducing power and removes free radical;C. the gold of chelating starting lipid peroxidation
Belong to ion, to cut off the chain reaction of free radical, plays antioxidation.Grape seed extract is cheap, and has good
Good antioxidant activity, has no toxic side effect, is the new and effective antioxidant for having development potentiality in natural.
A second object of the present invention is to provide a kind of systems of above-mentioned infant allergic dermatitis tailored version clinical nutrition formula
Preparation Method method comprising following steps: weighing each raw material of predetermined amount, wherein vitamin, composite mineral matter, integration of drinking and medicinal herbs at
Point, fat and new resource food it is previously prepared at premix;Premix and 2% maltodextrin are first mixed 5~15 minutes;By its
Its raw material is mixed according to principle addition incremental step by step, is mixed 10~30 minutes, is discharged, packing.
Further, above-mentioned each raw material is the raw material for the powder type that partial size is 50~200 μm, before configuration and is configured
Cheng Houjun passes through sterilization processing.
Further, the dosage form of the nutrient formulation includes nutrient powder, nutrition emulsion, capsule, tablet, pill, takes orally
Liquid etc..
Compared with prior art, the invention has the following advantages:
Enteral nutrition preparation of the nutrient formulation of the present invention as infant allergic dermatitis, passes through dietary therapy conduct
A kind of ancillary measure of patients in remission.According to the theory of China's Chinese Traditional Medicine, by substantially former by the dietotherapy controlled to demonstrate,prove
Then, in conjunction with patient's constitutive character, the Chinese medicine of one or more integration of drinking and medicinal herbs, new resource food, the benefit that can be used for food are used
Raw bacterium, amino acid, small peptide class, unsaturated fatty acid, water-soluble dietary fiber, the multivitamin with anti-oxidation function and more
Kind minerals are full nutrition or non-whole nutritional formula food, have effects that prevent and alleviate infant allergic dermatitis symptom.
Specific embodiment
The present invention provides a kind of infant allergic dermatitis tailored version clinical nutrition formula, which is characterized in that including such as the following group
Point and its parts by weight: 23~35 parts of protein, fat 28~37 parts, 18~23 parts of dietary fiber, 3~6 parts of new resource food,
2~15 parts of integration of drinking and medicinal herbs ingredient, 4~7 parts of magnesium gluconate, 0.4~0.6 part of calcium, 0.015~0.02 part of iron, zinc 0.010~
0.015 part, 0.001~0.0015 part of vitamin A, vitamin D30.0004~0.0008 part, vitamin E 0.01~0.03
Part, vitamin B10.001~0.005 part, vitamin B20.001~0.004 part, vitamin B60.001~0.004 part, dimension
Raw element B120.000002~0.000008 part, 0.1~0.3 part of vitamin C, 0.003~0.007 part of pantothenic acid, niacin 0.01~
0.02 part, 0.01~0.04 part of folic acid, 0.01~0.5 part of grape seed extract, 0.5~2 part of Kelp Powder.
With reference to embodiment, the specific embodiment of the present invention is further described.Following embodiment is only used for more
Add and clearly demonstrate technical solution of the present invention, and not intended to limit the protection scope of the present invention.
Embodiment 1
Infant allergic dermatitis tailored version clinical nutrition formula of the present invention includes following components:
Linseed oil microcapsule powder 24g, hydrolyzing lactoalbumin powder 20g, oligofructose 20g, Isin glue collagen Gly-His-Lys 6g, fish oil
The luxuriant Cillium 4g of microcapsule powder 6g, magnesium gluconate 6g, circle, dandelion powder 3g, hawthorn powder 2g, yam flour 2g, Kelp Powder 2g,
Calcium 0.5g, iron 0.017g, zinc 0.013g, vitamin A 0.0012g, vitamin D30.0006g, vitamin E 0.02g, dimension life
Plain B10.002g, vitamin B20.002g, vitamin B60.002g, vitamin B12It is 0.000004g, vitamin C 0.2g, general
Sour 0.005g, niacin 0.015g, folic acid 0.03g, grape seed extract 0.02g.
Preparation method: each component is weighed according to component table, wherein vitamin, minerals, integration of drinking and medicinal herbs, fat and new resources
Raw-food material is first prepared into preparation premix according to table;Premix and 2% maltodextrin are first mixed 10 minutes;Then by it
Its material puts into mixing machine according to principle incremental step by step, mixes 20 minutes, discharging, weighing record, packing.
Embodiment 2
Infant allergic dermatitis tailored version clinical nutrition formula of the present invention includes following components:
Linseed oil microcapsule powder 29g, hydrolyzing lactoalbumin powder 20g, oligofructose 20g, Isin glue collagen Gly-His-Lys 6g, fish oil
The luxuriant Cillium 4g of microcapsule powder 6g, magnesium gluconate 6g, circle, dandelion powder 1g, hawthorn powder 1g, yam flour 1g, Kelp Powder 1g,
Calcium 0.5g, iron 0.017g, zinc 0.013g, vitamin A 0.0012g, vitamin D30.0006g, vitamin E 0.02g, dimension life
Plain B10.002g, vitamin B20.002g, vitamin B60.002g, vitamin B12It is 0.000004g, vitamin C 0.2g, general
Sour 0.005g, niacin 0.015g, folic acid 0.03g, grape seed extract 0.02g.
Preparation method: each component is weighed according to component table, wherein vitamin, minerals, integration of drinking and medicinal herbs, fat and new resources
Raw-food material is first prepared into preparation premix according to table;Premix and 2% maltodextrin are first mixed 10 minutes;Then by it
Its material puts into mixing machine according to principle incremental step by step, mixes 20 minutes, discharging, weighing record, packing.
Embodiment 3
Infant allergic dermatitis tailored version clinical nutrition formula of the present invention includes following components:
Linseed oil microcapsule powder 29g, hydrolyzing lactoalbumin powder 25g, oligofructose 20g, Isin glue collagen Gly-His-Lys 6g, fish oil
The luxuriant Cillium 4g of microcapsule powder 1g, magnesium gluconate 6g, circle, dandelion powder 1g, hawthorn powder 1g, yam flour 1g, Kelp Powder 1g,
Calcium 0.5g, iron 0.017g, zinc 0.013g, vitamin A 0.0012g, vitamin D30.0006g, vitamin E 0.02g, dimension life
Plain B10.002g, vitamin B20.002g, vitamin B60.002g, vitamin B12It is 0.000004g, vitamin C 0.2g, general
Sour 0.005g, niacin 0.015g, folic acid 0.03g, grape seed extract 0.01g.
Preparation method: each component is weighed according to component table, wherein vitamin, minerals, integration of drinking and medicinal herbs, fat and new resources
Raw-food material is first prepared into preparation premix according to table;Premix and 2% maltodextrin are first mixed 10 minutes;Then by it
Its material puts into mixing machine according to principle incremental step by step, mixes 20 minutes, discharging, weighing record, packing.
Embodiment 4
Infant allergic dermatitis tailored version clinical nutrition formula of the present invention includes following components:
Linseed oil microcapsule powder 22g, hydrolyzing lactoalbumin powder 23g, oligofructose 22g, Isin glue collagen Gly-His-Lys 8g, smart ammonia
The luxuriant Cillium 3g of sour 1.5g, glutamine 1.5g, fish oil microcapsule powder 8g, magnesium gluconate 6g, circle, chitosan 3g, Radix Glycyrrhizae
Powder 0.2g, Poria cocos powder 0.2g, peach kernel powder 0.2g, sophora flower powder 0.2g, rhizoma imperatae powder 0.2g, coix seed powder 0.2g, purslane powder
0.2g, lily root flour 0.2g, honeysuckle powder 0.2g, herba houttuyniae powder 0.2g, gardenia powder 0.2g, purple perilla seed powder 0.2g, dandelion powder 2g,
Hawthorn powder 2g, yam flour 2g, Kelp Powder 2g, calcium 0.5g, iron 0.017g, zinc 0.013g, selenium 0.015g, vitamin A 0.0012g,
Vitamin D30.0006g, vitamin E 0.02g, vitamin B10.002g, vitamin B20.002g, vitamin B6
0.002g, vitamin B120.000004g, vitamin C 0.2g, pantothenic acid 0.005g, niacin 0.015g, folic acid 0.03g, grape pip
Extract 0.01g, lactobacillus acidophilus NCFM 2g, bifidobacterium lactis HN019 2g.
Preparation method: each component is weighed according to component table, wherein vitamin, minerals, integration of drinking and medicinal herbs, fat and new resources
Raw-food material is first prepared into preparation premix according to table;Premix and 2% maltodextrin are first mixed 10 minutes;Then by it
Its material puts into mixing machine according to principle incremental step by step, mixes 20 minutes, discharging, weighing record, packing.
Application Example
The present embodiment carries out treatment infant allergic dermatitis clinical experimental study using the nutrient powder of Examples 1 to 4 preparation,
It chooses 100 atopic dermatitis patients, and female 22, average age 6 years old, it is non-to have excluded organic disease, wound etc. by male 28
Anaphylaxis case.Stochastic averagina is divided into five groups, respectively control group, example 1 group, 2 groups of embodiment, 3 groups of embodiment and implementation
4 groups of example.Control group gives hydrocortisone ointment, uses by package insert, and 7 days are 1 course for the treatment of.Example 1 group, embodiment
2 groups, 3 groups of embodiment and 4 groups of embodiment give nutrient powder obtained by the embodiment of the present invention 1~4 respectively, dosage be two times a day,
1 100mg.
Criterion of therapeutical effect: invalid-patient symptom absolutely not improves, and has exacerbation sign;Effective-patient symptom, which has, significantly to be changed
It is kind, but do not completely disappear yet;Effectively-patient symptom completely disappears.Side reaction: itch, redness, secondary infection, allergic reaction
Etc. common side reaction.The experimental results are shown inthe following table:
Experimental group | Test number of cases | In vain | It is effective | Effectively | Recurrence | Side reaction |
Control group | 20 | 3 | 10 | 7 | 8 | 1 |
Example 1 group | 20 | 2 | 12 | 6 | 4 | 0 |
2 groups of embodiment | 20 | 2 | 9 | 9 | 3 | 0 |
3 groups of embodiment | 20 | 1 | 13 | 6 | 4 | 0 |
4 groups of embodiment | 20 | 1 | 8 | 11 | 2 | 0 |
From the foregoing, it will be observed that compared with the control group, nutrient formulation of the present invention for allergic dermatitis therapeutic effect with
Hydrocortisone ointment is suitable, even better than hydrocortisone ointment, it was demonstrated that it can effectively prevent and assist in the treatment of anaphylaxis
Dermatitis, and its recurrent is lower, side reaction is smaller.This illustrates nutrient formulation prepared by the present invention, can be used as infant allergic skin
Scorching daily nutrition equilibrium preparation, and gastral adverse reaction caused by drug therapy can be effectively relieved in it, assist in the treatment of small
Youngster's allergic dermatitis.
The present invention is by selecting reasonable basal nutrient element, based on the nutrition intake of infant allergic dermatitis patients, to each
The proportion of component is adaptively adjusted, while adding the specific nutrient that there is protection function of intestinal canal and nutrition auxiliary to support,
To realize nutrition equilibrium, improves infant allergic dermatitis patients trophic structure, improve its inflammatory reaction and body health situation.
Specific embodiments of the present invention are described in detail above, but it is only used as example, the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, the equivalent modifications and replace that any couple of present invention carries out
In generation, is also all among scope of the invention.Therefore, without departing from the spirit and scope of the invention made by equal transformation and repair
Change, all should be contained within the scope of the invention.
Claims (10)
1. a kind of infant allergic dermatitis tailored version clinical nutrition formula, which is characterized in that including following component and its parts by weight
Number: 23~35 parts of protein, fatty 28~37 parts, 18~23 parts of dietary fiber, 3~6 parts of new resource food, integration of drinking and medicinal herbs ingredient
2~15 parts, 4~7 parts of magnesium gluconate, 0.4~0.6 part of calcium, 0.015~0.02 part of iron, 0.010~0.015 part of zinc, vitamin
0.001~0.0015 part of A, vitamin D30.0004~0.0008 part, 0.01~0.03 part of vitamin E, vitamin B1
0.001~0.005 part, vitamin B20.001~0.004 part, vitamin B60.001~0.004 part, vitamin B12
0.000002~0.000008 part, 0.1~0.3 part of vitamin C, 0.003~0.007 part of pantothenic acid, 0.01~0.02 part of niacin,
0.01~0.04 part of folic acid, 0.01~0.5 part of grape seed extract, 0.5~2 part of Kelp Powder.
2. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
Protein is selected from hydrolyzing lactoalbumin powder, concentrated whey protein powder, soybean protein isolate, dried whole-egg, bovine colostrum, whole milk
Powder, ovalbumin peptide, soybean peptide, ocean fish oligopeptide, wheat oligopeptide, corn oligopeptide powder, alpha lactalbumin powder, collagen egg
At least one of white Gly-His-Lys, amino acid.
3. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 2, which is characterized in that described
Amino acid be selected from L-Glutamine, glycine, lysine, serine, arginine, alanine, methionine, tryptophan, leucine,
Isoleucine, valine, histidine, tyrosine, phenylalanine, citrulling, ornithine, aspartic acid, threonine, glutamic acid,
At least one of cystine.
4. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
Integration of drinking and medicinal herbs ingredient be selected from Radix Glycyrrhizae, Poria cocos, peach kernel, sophora flower, rhizoma imperatae, semen coicis, purslane, lily, honeysuckle, cordate houttuynia,
At least one of cape jasmine, dandelion, purple perilla seed, hawthorn, Chinese yam.
5. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
New resource food be selected from DHA algal oil, arachidonic acid oil, gamma-linolenic acid oil, peony seed oil, tea seed oil, samara oil,
Imperial rice bran oil, conjugated linoleic acid, eucommia ulmoides seed oil, Oligomeric manna sugar, wheat oligopeptide, chitosan, ginseng, zeaxanthin, hydrolysis egg
At least one of luxuriant Cillium of bloom, circle.
6. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
Fat selected from olive oil microcapsule powder, tea oil microcapsule powder, fish oil microcapsule powder, docosahexaenoic acid grease, arachidonic acid oil,
At least one of linseed oil microcapsule powder.
7. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
Dietary fiber be selected from inulin, polydextrose, galactooligosaccharide, oligofructose, xylo-oligosaccharide, oligoisomaltose, resistant dextrin,
At least one of grain dietary fibers such as soybean fiber.
8. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
Nutrient formulation further includes 1~5 part of probiotics, and the probiotics is selected from Bifidobacterium, lactobacillus, streptococcus, acidophilus cream
Bacillus NCFM, animal bifidobacteria Bb-12, bifidobacterium lactis HN019, bifidobacterium lactis Bi-07, Lactobacillus rhamnosus LGG, mouse
At least one of Lee's sugar lactobacillus HN001, lactobacillus fermenti CECT5716, bifidobacterium breve M-16V.
9. a kind of infant allergic dermatitis tailored version clinical nutrition formula according to claim 1, which is characterized in that described
Nutrient formulation further includes 0.003~0.05 part of selenium, and the selenium is in sodium selenite, selenium-enriched edible mushroom powder, Se-enriched yeast
It is at least one.
10. a kind of preparation of such as infant allergic dermatitis tailored version clinical nutrition formula according to any one of claims 1 to 9
Method, which comprises the steps of: weigh each raw material of predetermined amount, wherein vitamin, composite mineral matter, medicine food are same
Derived components, fat and new resource food are previously prepared at premix;Premix and 2% maltodextrin are first mixed 5~15 minutes;
Other raw materials are mixed according to principle addition incremental step by step, mixes 10~30 minutes, discharges, packing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910606011.7A CN110432482A (en) | 2019-07-05 | 2019-07-05 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910606011.7A CN110432482A (en) | 2019-07-05 | 2019-07-05 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110432482A true CN110432482A (en) | 2019-11-12 |
Family
ID=68429417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910606011.7A Pending CN110432482A (en) | 2019-07-05 | 2019-07-05 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110432482A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112425776A (en) * | 2020-12-11 | 2021-03-02 | 安徽国膳生物科技有限公司 | Medicated diet for people with eczema |
CN113875792A (en) * | 2021-10-15 | 2022-01-04 | 重庆市三品功能食品研究院有限公司 | Meal replacement compressed biscuit beneficial to maintaining health of skin mucosa and preparation method thereof |
WO2023237680A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
WO2023237681A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
WO2023237673A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
WO2023237677A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104187710A (en) * | 2014-07-28 | 2014-12-10 | 胡安然 | Total-nutrition formula food for inflammatory bowel diseases |
CN104855984A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with allergic rhinitis |
CN108013454A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof |
CN108013453A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
CN108703365A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
CN109329902A (en) * | 2018-07-30 | 2019-02-15 | 上海奥医生物医药科技有限公司 | A kind of leukemia of children tailored version clinical nutrition formula and preparation method thereof |
-
2019
- 2019-07-05 CN CN201910606011.7A patent/CN110432482A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104187710A (en) * | 2014-07-28 | 2014-12-10 | 胡安然 | Total-nutrition formula food for inflammatory bowel diseases |
CN104855984A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with allergic rhinitis |
CN108013454A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof |
CN108013453A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
CN108703365A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
CN109329902A (en) * | 2018-07-30 | 2019-02-15 | 上海奥医生物医药科技有限公司 | A kind of leukemia of children tailored version clinical nutrition formula and preparation method thereof |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112425776A (en) * | 2020-12-11 | 2021-03-02 | 安徽国膳生物科技有限公司 | Medicated diet for people with eczema |
CN113875792A (en) * | 2021-10-15 | 2022-01-04 | 重庆市三品功能食品研究院有限公司 | Meal replacement compressed biscuit beneficial to maintaining health of skin mucosa and preparation method thereof |
WO2023237680A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
WO2023237681A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
WO2023237673A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
WO2023237677A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and bifidobacterium animalis ssp. lactis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110432482A (en) | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof | |
CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
CN110226744A (en) | A kind of prostatitis tailored version clinical nutrition formula and preparation method thereof | |
CN104996994A (en) | Chronic obstructive pulmonary disease specific full nutritional formula food | |
CN104839683A (en) | Medical formula food for people with constipation | |
CN107440107A (en) | It is a kind of to eat the food formula of special diet containing small peptide for pregnancy reaction crowd | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN108968037A (en) | Senile dementia full nutrition formula food | |
CN110214942A (en) | A kind of hyperthyroidism tailored version Nutrition formula and preparation method thereof | |
CN104839708A (en) | Chronic obstructive pulmonary disease non-total nutrient formula food | |
CN104872638A (en) | Non-total nutrient formula food for constipation patients | |
CN104839662A (en) | Respiratory system disease medical formula food | |
CN107334156A (en) | Lactagogue full nutrition formula food | |
CN108936607A (en) | Chronic Obstructive Pulmonary Disease full nutrition formula food | |
CN105029392A (en) | Medical formula food for nasopharynx cancer | |
CN104839685A (en) | Medical formula food for people with wound, infection, operation, and at other emergency states | |
CN104839670A (en) | Specific endowment constitution medical formula food | |
CN104256656A (en) | Full-nutrition formulated food for fatty acid metabolic disorder | |
CN108618140A (en) | The antenatal conditioning medicine formula food of pregnant woman | |
CN105029402A (en) | Medical formula food for pancreatitis | |
CN104839654A (en) | Medical formula food for acne-removing | |
CN104323278A (en) | Full-nutrition formula food for liver cancer | |
CN104146267A (en) | Full-nutrition formulated food for lupus erythematosus | |
CN107467654B (en) | Kelp and sea cucumber compound extract and preparation method and application thereof | |
CN104996991A (en) | Lupus erythematosus medical formula food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191112 |
|
RJ01 | Rejection of invention patent application after publication |